aluates Reports

$ 0.0

Automative

Global Macrophage Anticancer Therapy Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-29U18880

BUY CHAPTERS

Global Macrophage Anticancer Therapy Market Research Report 2025

Code: QYRE-Auto-29U18880

Report

March 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Shaanxi Jushi Kangji Biotechnology

Macrophage Anticancer Therapy Market Size

The global market for Macrophage Anticancer Therapy was valued at US$ 431 million in the year 2024 and is projected to reach a revised size of US$ 605 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Macrophage Anticancer Therapy Market

Macrophage anticancer therapy is an immunotherapy that utilizes the anticancer activity of macrophages. Macrophages are important cells in the immune system with multiple functions, including phagocytosis, killing of pathogens and tumor cells, and regulation of immune responses. In macrophage anticancer therapy, macrophages are activated or modified to more effectively recognize and attack tumor cells. This therapy can be achieved through various routes, such as direct injection of activated macrophages into the tumor site or using gene engineering techniques to modify macrophages to have stronger anticancer abilities. Macrophage anticancer therapy provides new ideas and methods for tumor treatment and brings hope to cancer patients.

North American market for Macrophage Anticancer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Macrophage Anticancer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Macrophage Anticancer Therapy in Solid Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Macrophage Anticancer Therapy include Carisma, Myeloid Therapeutics, Inceptor Bio, Cell-Origin, Rocrock Bio, Shaanxi Jushi Kangji Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Macrophage Anticancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macrophage Anticancer Therapy.

The Macrophage Anticancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macrophage Anticancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macrophage Anticancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Macrophage Anticancer Therapy Market Report

Report Metric	Details
Report Name	Macrophage Anticancer Therapy Market
Accounted market size in year	US$ 431 million
Forecasted market size in 2031	US$ 605 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CD19 HER2 Others
Segment by Application	Solid Tumors Non-Solid Tumors
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Carisma, Myeloid Therapeutics, Inceptor Bio, Cell-Origin, Rocrock Bio, Shaanxi Jushi Kangji Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macrophage Anticancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Macrophage Anticancer Therapy Market growing?

Ans: The Macrophage Anticancer Therapy Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Macrophage Anticancer Therapy Market size in 2031?

Ans: The Macrophage Anticancer Therapy Market size in 2031 will be US$ 605 million.

Who are the main players in the Macrophage Anticancer Therapy Market report?

Ans: The main players in the Macrophage Anticancer Therapy Market are Carisma, Myeloid Therapeutics, Inceptor Bio, Cell-Origin, Rocrock Bio, Shaanxi Jushi Kangji Biotechnology

What are the Application segmentation covered in the Macrophage Anticancer Therapy Market report?

Ans: The Applications covered in the Macrophage Anticancer Therapy Market report are Solid Tumors, Non-Solid Tumors

What are the Type segmentation covered in the Macrophage Anticancer Therapy Market report?

Ans: The Types covered in the Macrophage Anticancer Therapy Market report are CD19, HER2, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Macrophage Anticancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CD19

1.2.3 HER2

1.2.4 Others

1.3 Market by Application

1.3.1 Global Macrophage Anticancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumors

1.3.3 Non-Solid Tumors

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Macrophage Anticancer Therapy Market Perspective (2020-2031)

2.2 Global Macrophage Anticancer Therapy Growth Trends by Region

2.2.1 Global Macrophage Anticancer Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Macrophage Anticancer Therapy Historic Market Size by Region (2020-2025)

2.2.3 Macrophage Anticancer Therapy Forecasted Market Size by Region (2026-2031)

2.3 Macrophage Anticancer Therapy Market Dynamics

2.3.1 Macrophage Anticancer Therapy Industry Trends

2.3.2 Macrophage Anticancer Therapy Market Drivers

2.3.3 Macrophage Anticancer Therapy Market Challenges

2.3.4 Macrophage Anticancer Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Macrophage Anticancer Therapy Players by Revenue

3.1.1 Global Top Macrophage Anticancer Therapy Players by Revenue (2020-2025)

3.1.2 Global Macrophage Anticancer Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top Macrophage Anticancer Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Macrophage Anticancer Therapy Revenue

3.4 Global Macrophage Anticancer Therapy Market Concentration Ratio

3.4.1 Global Macrophage Anticancer Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Macrophage Anticancer Therapy Revenue in 2024

3.5 Global Key Players of Macrophage Anticancer Therapy Head office and Area Served

3.6 Global Key Players of Macrophage Anticancer Therapy, Product and Application

3.7 Global Key Players of Macrophage Anticancer Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Macrophage Anticancer Therapy Breakdown Data by Type

4.1 Global Macrophage Anticancer Therapy Historic Market Size by Type (2020-2025)

4.2 Global Macrophage Anticancer Therapy Forecasted Market Size by Type (2026-2031)

5 Macrophage Anticancer Therapy Breakdown Data by Application

5.1 Global Macrophage Anticancer Therapy Historic Market Size by Application (2020-2025)

5.2 Global Macrophage Anticancer Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Macrophage Anticancer Therapy Market Size (2020-2031)

6.2 North America Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Macrophage Anticancer Therapy Market Size by Country (2020-2025)

6.4 North America Macrophage Anticancer Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Macrophage Anticancer Therapy Market Size (2020-2031)

7.2 Europe Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Macrophage Anticancer Therapy Market Size by Country (2020-2025)

7.4 Europe Macrophage Anticancer Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Macrophage Anticancer Therapy Market Size (2020-2031)

8.2 Asia-Pacific Macrophage Anticancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Macrophage Anticancer Therapy Market Size (2020-2031)

9.2 Latin America Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Macrophage Anticancer Therapy Market Size by Country (2020-2025)

9.4 Latin America Macrophage Anticancer Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Macrophage Anticancer Therapy Market Size (2020-2031)

10.2 Middle East & Africa Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Carisma

11.1.1 Carisma Company Details

11.1.2 Carisma Business Overview

11.1.3 Carisma Macrophage Anticancer Therapy Introduction

11.1.4 Carisma Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.1.5 Carisma Recent Development

11.2 Myeloid Therapeutics

11.2.1 Myeloid Therapeutics Company Details

11.2.2 Myeloid Therapeutics Business Overview

11.2.3 Myeloid Therapeutics Macrophage Anticancer Therapy Introduction

11.2.4 Myeloid Therapeutics Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.2.5 Myeloid Therapeutics Recent Development

11.3 Inceptor Bio

11.3.1 Inceptor Bio Company Details

11.3.2 Inceptor Bio Business Overview

11.3.3 Inceptor Bio Macrophage Anticancer Therapy Introduction

11.3.4 Inceptor Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.3.5 Inceptor Bio Recent Development

11.4 Cell-Origin

11.4.1 Cell-Origin Company Details

11.4.2 Cell-Origin Business Overview

11.4.3 Cell-Origin Macrophage Anticancer Therapy Introduction

11.4.4 Cell-Origin Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.4.5 Cell-Origin Recent Development

11.5 Rocrock Bio

11.5.1 Rocrock Bio Company Details

11.5.2 Rocrock Bio Business Overview

11.5.3 Rocrock Bio Macrophage Anticancer Therapy Introduction

11.5.4 Rocrock Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.5.5 Rocrock Bio Recent Development

11.6 Shaanxi Jushi Kangji Biotechnology

11.6.1 Shaanxi Jushi Kangji Biotechnology Company Details

11.6.2 Shaanxi Jushi Kangji Biotechnology Business Overview

11.6.3 Shaanxi Jushi Kangji Biotechnology Macrophage Anticancer Therapy Introduction

11.6.4 Shaanxi Jushi Kangji Biotechnology Revenue in Macrophage Anticancer Therapy Business (2020-2025)

11.6.5 Shaanxi Jushi Kangji Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Shaanxi Jushi Kangji Biotechnology

List of Tables

Table 1. Global Macrophage Anticancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CD19

Table 3. Key Players of HER2

Table 4. Key Players of Others

Table 5. Global Macrophage Anticancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Macrophage Anticancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Macrophage Anticancer Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Macrophage Anticancer Therapy Market Share by Region (2020-2025)

Table 9. Global Macrophage Anticancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Macrophage Anticancer Therapy Market Share by Region (2026-2031)

Table 11. Macrophage Anticancer Therapy Market Trends

Table 12. Macrophage Anticancer Therapy Market Drivers

Table 13. Macrophage Anticancer Therapy Market Challenges

Table 14. Macrophage Anticancer Therapy Market Restraints

Table 15. Global Macrophage Anticancer Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Macrophage Anticancer Therapy Market Share by Players (2020-2025)

Table 17. Global Top Macrophage Anticancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macrophage Anticancer Therapy as of 2024)

Table 18. Ranking of Global Top Macrophage Anticancer Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Macrophage Anticancer Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Macrophage Anticancer Therapy, Headquarters and Area Served

Table 21. Global Key Players of Macrophage Anticancer Therapy, Product and Application

Table 22. Global Key Players of Macrophage Anticancer Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Macrophage Anticancer Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Macrophage Anticancer Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global Macrophage Anticancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Macrophage Anticancer Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global Macrophage Anticancer Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Macrophage Anticancer Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global Macrophage Anticancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Macrophage Anticancer Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Macrophage Anticancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Carisma Company Details

Table 48. Carisma Business Overview

Table 49. Carisma Macrophage Anticancer Therapy Product

Table 50. Carisma Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 51. Carisma Recent Development

Table 52. Myeloid Therapeutics Company Details

Table 53. Myeloid Therapeutics Business Overview

Table 54. Myeloid Therapeutics Macrophage Anticancer Therapy Product

Table 55. Myeloid Therapeutics Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 56. Myeloid Therapeutics Recent Development

Table 57. Inceptor Bio Company Details

Table 58. Inceptor Bio Business Overview

Table 59. Inceptor Bio Macrophage Anticancer Therapy Product

Table 60. Inceptor Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 61. Inceptor Bio Recent Development

Table 62. Cell-Origin Company Details

Table 63. Cell-Origin Business Overview

Table 64. Cell-Origin Macrophage Anticancer Therapy Product

Table 65. Cell-Origin Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 66. Cell-Origin Recent Development

Table 67. Rocrock Bio Company Details

Table 68. Rocrock Bio Business Overview

Table 69. Rocrock Bio Macrophage Anticancer Therapy Product

Table 70. Rocrock Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 71. Rocrock Bio Recent Development

Table 72. Shaanxi Jushi Kangji Biotechnology Company Details

Table 73. Shaanxi Jushi Kangji Biotechnology Business Overview

Table 74. Shaanxi Jushi Kangji Biotechnology Macrophage Anticancer Therapy Product

Table 75. Shaanxi Jushi Kangji Biotechnology Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)

Table 76. Shaanxi Jushi Kangji Biotechnology Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Macrophage Anticancer Therapy Picture

Figure 2. Global Macrophage Anticancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Macrophage Anticancer Therapy Market Share by Type: 2024 VS 2031

Figure 4. CD19 Features

Figure 5. HER2 Features

Figure 6. Others Features

Figure 7. Global Macrophage Anticancer Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Macrophage Anticancer Therapy Market Share by Application: 2024 VS 2031

Figure 9. Solid Tumors Case Studies

Figure 10. Non-Solid Tumors Case Studies

Figure 11. Macrophage Anticancer Therapy Report Years Considered

Figure 12. Global Macrophage Anticancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Macrophage Anticancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Macrophage Anticancer Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global Macrophage Anticancer Therapy Market Share by Players in 2024

Figure 16. Global Macrophage Anticancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Macrophage Anticancer Therapy Revenue in 2024

Figure 18. North America Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Macrophage Anticancer Therapy Market Share by Country (2020-2031)

Figure 20. United States Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Macrophage Anticancer Therapy Market Share by Country (2020-2031)

Figure 24. Germany Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Macrophage Anticancer Therapy Market Share by Region (2020-2031)

Figure 32. China Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Macrophage Anticancer Therapy Market Share by Country (2020-2031)

Figure 40. Mexico Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Macrophage Anticancer Therapy Market Share by Country (2020-2031)

Figure 44. Turkey Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Carisma Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 48. Myeloid Therapeutics Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 49. Inceptor Bio Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 50. Cell-Origin Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 51. Rocrock Bio Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 52. Shaanxi Jushi Kangji Biotechnology Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CAR M Cell Therapy Market Research Report 2025

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Immunotherapy Drugs Market Research Report 2024

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Cancer Immunotherapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Anticancer Drugs Market Research Report 2025

Global Heavy Ion Therapy for Cancer Market Research Report 2024

Global Cancer Particle Therapy Market Research Report 2024

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions